0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hydrogel-based Drug Delivery Device Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-29W17486
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Hydrogel based Drug Delivery Device Market Research Report 2024
BUY CHAPTERS

Global Hydrogel-based Drug Delivery Device Market Research Report 2026

Code: QYRE-Auto-29W17486
Report
2026-03-03
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hydrogel-based Drug Delivery Device Market

The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hydrogel-based Drug Delivery Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
The North American market for Hydrogel-based Drug Delivery Device is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Hydrogel-based Drug Delivery Device is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Hydrogel-based Drug Delivery Device include AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Hydrogel-based Drug Delivery Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hydrogel-based Drug Delivery Device. The Hydrogel-based Drug Delivery Device market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hydrogel-based Drug Delivery Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hydrogel-based Drug Delivery Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hydrogel-based Drug Delivery Device Market Report

Report Metric Details
Report Name Hydrogel-based Drug Delivery Device Market
Segment by Type
  • Oral
  • Buccal
  • Rectal
  • Vaginal
  • Other
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, Pfizer Inc., Aquestive Therapeutics Inc., ZIM LABORATORIES LIMITED, IntelGenx Corp., NEXGEL, Bliss GVS Pharma Ltd., Teika Pharmaceutical Co. Ltd., Medherant Limited, Galderma, Johnson & Johnson, Bausch and Lomb, Ferring B.V
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hydrogel-based Drug Delivery Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Hydrogel-based Drug Delivery Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Hydrogel-based Drug Delivery Device Market report?

Ans: The main players in the Hydrogel-based Drug Delivery Device Market are AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, Pfizer Inc., Aquestive Therapeutics Inc., ZIM LABORATORIES LIMITED, IntelGenx Corp., NEXGEL, Bliss GVS Pharma Ltd., Teika Pharmaceutical Co. Ltd., Medherant Limited, Galderma, Johnson & Johnson, Bausch and Lomb, Ferring B.V

What are the Application segmentation covered in the Hydrogel-based Drug Delivery Device Market report?

Ans: The Applications covered in the Hydrogel-based Drug Delivery Device Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Hydrogel-based Drug Delivery Device Market report?

Ans: The Types covered in the Hydrogel-based Drug Delivery Device Market report are Oral, Buccal, Rectal, Vaginal, Other

1 Hydrogel-based Drug Delivery Device Market Overview
1.1 Product Definition
1.2 Hydrogel-based Drug Delivery Device by Type
1.2.1 Global Hydrogel-based Drug Delivery Device Market Value by Type: 2025 vs 2032
1.2.2 Oral
1.2.3 Buccal
1.2.4 Rectal
1.2.5 Vaginal
1.2.6 Other
1.3 Hydrogel-based Drug Delivery Device by Application
1.3.1 Global Hydrogel-based Drug Delivery Device Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Hydrogel-based Drug Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Hydrogel-based Drug Delivery Device Revenue 2021–2032
1.4.2 Global Hydrogel-based Drug Delivery Device Sales 2021–2032
1.4.3 Global Hydrogel-based Drug Delivery Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Hydrogel-based Drug Delivery Device Market Competition by Manufacturers
2.1 Global Hydrogel-based Drug Delivery Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hydrogel-based Drug Delivery Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hydrogel-based Drug Delivery Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Product Types and Applications
2.7 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Date of Entry into the Industry
2.8 Global Hydrogel-based Drug Delivery Device Market Competitive Situation and Trends
2.8.1 Global Hydrogel-based Drug Delivery Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hydrogel-based Drug Delivery Device Players Market Share by Revenue
2.8.3 Global Hydrogel-based Drug Delivery Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hydrogel-based Drug Delivery Device Market Scenario by Region
3.1 Global Hydrogel-based Drug Delivery Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hydrogel-based Drug Delivery Device Sales by Region: 2021–2032
3.2.1 Global Hydrogel-based Drug Delivery Device Sales by Region: 2021–2026
3.2.2 Global Hydrogel-based Drug Delivery Device Sales by Region: 2027–2032
3.3 Global Hydrogel-based Drug Delivery Device Revenue by Region: 2021–2032
3.3.1 Global Hydrogel-based Drug Delivery Device Revenue by Region: 2021–2026
3.3.2 Global Hydrogel-based Drug Delivery Device Revenue by Region: 2027–2032
3.4 North America Hydrogel-based Drug Delivery Device Market Facts & Figures by Country
3.4.1 North America Hydrogel-based Drug Delivery Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hydrogel-based Drug Delivery Device Sales by Country (2021–2032)
3.4.3 North America Hydrogel-based Drug Delivery Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hydrogel-based Drug Delivery Device Market Facts & Figures by Country
3.5.1 Europe Hydrogel-based Drug Delivery Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hydrogel-based Drug Delivery Device Sales by Country (2021–2032)
3.5.3 Europe Hydrogel-based Drug Delivery Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hydrogel-based Drug Delivery Device Market Facts & Figures by Region
3.6.1 Asia Pacific Hydrogel-based Drug Delivery Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hydrogel-based Drug Delivery Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Hydrogel-based Drug Delivery Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hydrogel-based Drug Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Hydrogel-based Drug Delivery Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hydrogel-based Drug Delivery Device Sales by Country (2021–2032)
3.7.3 Latin America Hydrogel-based Drug Delivery Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hydrogel-based Drug Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Hydrogel-based Drug Delivery Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hydrogel-based Drug Delivery Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hydrogel-based Drug Delivery Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hydrogel-based Drug Delivery Device Sales by Type (2021–2032)
4.1.1 Global Hydrogel-based Drug Delivery Device Sales by Type (2021–2026)
4.1.2 Global Hydrogel-based Drug Delivery Device Sales by Type (2027–2032)
4.1.3 Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2021–2032)
4.2 Global Hydrogel-based Drug Delivery Device Revenue by Type (2021–2032)
4.2.1 Global Hydrogel-based Drug Delivery Device Revenue by Type (2021–2026)
4.2.2 Global Hydrogel-based Drug Delivery Device Revenue by Type (2027–2032)
4.2.3 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2021–2032)
4.3 Global Hydrogel-based Drug Delivery Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hydrogel-based Drug Delivery Device Sales by Application (2021–2032)
5.1.1 Global Hydrogel-based Drug Delivery Device Sales by Application (2021–2026)
5.1.2 Global Hydrogel-based Drug Delivery Device Sales by Application (2027–2032)
5.1.3 Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2021–2032)
5.2 Global Hydrogel-based Drug Delivery Device Revenue by Application (2021–2032)
5.2.1 Global Hydrogel-based Drug Delivery Device Revenue by Application (2021–2026)
5.2.2 Global Hydrogel-based Drug Delivery Device Revenue by Application (2027–2032)
5.2.3 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2021–2032)
5.3 Global Hydrogel-based Drug Delivery Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca Plc.
6.1.1 AstraZeneca Plc. Company Information
6.1.2 AstraZeneca Plc. Description and Business Overview
6.1.3 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product Portfolio
6.1.5 AstraZeneca Plc. Recent Developments/Updates
6.2 Columbia Laboratories Inc.
6.2.1 Columbia Laboratories Inc. Company Information
6.2.2 Columbia Laboratories Inc. Description and Business Overview
6.2.3 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.2.5 Columbia Laboratories Inc. Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan Hydrogel-based Drug Delivery Device Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva Pharmaceuticals USA Inc.
6.4.1 Teva Pharmaceuticals USA Inc. Company Information
6.4.2 Teva Pharmaceuticals USA Inc. Description and Business Overview
6.4.3 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.4.5 Teva Pharmaceuticals USA Inc. Recent Developments/Updates
6.5 Blairex Laboratories Inc.
6.5.1 Blairex Laboratories Inc. Company Information
6.5.2 Blairex Laboratories Inc. Description and Business Overview
6.5.3 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.5.5 Blairex Laboratories Inc. Recent Developments/Updates
6.6 ARx LLC.
6.6.1 ARx LLC. Company Information
6.6.2 ARx LLC. Description and Business Overview
6.6.3 ARx LLC. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ARx LLC. Hydrogel-based Drug Delivery Device Product Portfolio
6.6.5 ARx LLC. Recent Developments/Updates
6.7 Endo International plc
6.7.1 Endo International plc Company Information
6.7.2 Endo International plc Description and Business Overview
6.7.3 Endo International plc Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Endo International plc Hydrogel-based Drug Delivery Device Product Portfolio
6.7.5 Endo International plc Recent Developments/Updates
6.8 BioDelivery Sciences International Inc.
6.8.1 BioDelivery Sciences International Inc. Company Information
6.8.2 BioDelivery Sciences International Inc. Description and Business Overview
6.8.3 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.8.5 BioDelivery Sciences International Inc. Recent Developments/Updates
6.9 Indivior PLC
6.9.1 Indivior PLC Company Information
6.9.2 Indivior PLC Description and Business Overview
6.9.3 Indivior PLC Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Indivior PLC Hydrogel-based Drug Delivery Device Product Portfolio
6.9.5 Indivior PLC Recent Developments/Updates
6.10 GSK Plc
6.10.1 GSK Plc Company Information
6.10.2 GSK Plc Description and Business Overview
6.10.3 GSK Plc Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 GSK Plc Hydrogel-based Drug Delivery Device Product Portfolio
6.10.5 GSK Plc Recent Developments/Updates
6.11 Pfizer Inc.
6.11.1 Pfizer Inc. Company Information
6.11.2 Pfizer Inc. Description and Business Overview
6.11.3 Pfizer Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Pfizer Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.11.5 Pfizer Inc. Recent Developments/Updates
6.12 Aquestive Therapeutics Inc.
6.12.1 Aquestive Therapeutics Inc. Company Information
6.12.2 Aquestive Therapeutics Inc. Description and Business Overview
6.12.3 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.12.5 Aquestive Therapeutics Inc. Recent Developments/Updates
6.13 ZIM LABORATORIES LIMITED
6.13.1 ZIM LABORATORIES LIMITED Company Information
6.13.2 ZIM LABORATORIES LIMITED Description and Business Overview
6.13.3 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product Portfolio
6.13.5 ZIM LABORATORIES LIMITED Recent Developments/Updates
6.14 IntelGenx Corp.
6.14.1 IntelGenx Corp. Company Information
6.14.2 IntelGenx Corp. Description and Business Overview
6.14.3 IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 IntelGenx Corp. Hydrogel-based Drug Delivery Device Product Portfolio
6.14.5 IntelGenx Corp. Recent Developments/Updates
6.15 NEXGEL
6.15.1 NEXGEL Company Information
6.15.2 NEXGEL Description and Business Overview
6.15.3 NEXGEL Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 NEXGEL Hydrogel-based Drug Delivery Device Product Portfolio
6.15.5 NEXGEL Recent Developments/Updates
6.16 Bliss GVS Pharma Ltd.
6.16.1 Bliss GVS Pharma Ltd. Company Information
6.16.2 Bliss GVS Pharma Ltd. Description and Business Overview
6.16.3 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product Portfolio
6.16.5 Bliss GVS Pharma Ltd. Recent Developments/Updates
6.17 Teika Pharmaceutical Co. Ltd.
6.17.1 Teika Pharmaceutical Co. Ltd. Company Information
6.17.2 Teika Pharmaceutical Co. Ltd. Description and Business Overview
6.17.3 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product Portfolio
6.17.5 Teika Pharmaceutical Co. Ltd. Recent Developments/Updates
6.18 Medherant Limited
6.18.1 Medherant Limited Company Information
6.18.2 Medherant Limited Description and Business Overview
6.18.3 Medherant Limited Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Medherant Limited Hydrogel-based Drug Delivery Device Product Portfolio
6.18.5 Medherant Limited Recent Developments/Updates
6.19 Galderma
6.19.1 Galderma Company Information
6.19.2 Galderma Description and Business Overview
6.19.3 Galderma Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Galderma Hydrogel-based Drug Delivery Device Product Portfolio
6.19.5 Galderma Recent Developments/Updates
6.20 Johnson & Johnson
6.20.1 Johnson & Johnson Company Information
6.20.2 Johnson & Johnson Description and Business Overview
6.20.3 Johnson & Johnson Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Johnson & Johnson Hydrogel-based Drug Delivery Device Product Portfolio
6.20.5 Johnson & Johnson Recent Developments/Updates
6.21 Bausch and Lomb
6.21.1 Bausch and Lomb Company Information
6.21.2 Bausch and Lomb Description and Business Overview
6.21.3 Bausch and Lomb Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Bausch and Lomb Hydrogel-based Drug Delivery Device Product Portfolio
6.21.5 Bausch and Lomb Recent Developments/Updates
6.22 Ferring B.V
6.22.1 Ferring B.V Company Information
6.22.2 Ferring B.V Description and Business Overview
6.22.3 Ferring B.V Hydrogel-based Drug Delivery Device Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Ferring B.V Hydrogel-based Drug Delivery Device Product Portfolio
6.22.5 Ferring B.V Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hydrogel-based Drug Delivery Device Industry Chain Analysis
7.2 Hydrogel-based Drug Delivery Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hydrogel-based Drug Delivery Device Production Mode & Process Analysis
7.4 Hydrogel-based Drug Delivery Device Sales and Marketing
7.4.1 Hydrogel-based Drug Delivery Device Sales Channels
7.4.2 Hydrogel-based Drug Delivery Device Distributors
7.5 Hydrogel-based Drug Delivery Device Customer Analysis
8 Hydrogel-based Drug Delivery Device Market Dynamics
8.1 Hydrogel-based Drug Delivery Device Industry Trends
8.2 Hydrogel-based Drug Delivery Device Market Drivers
8.3 Hydrogel-based Drug Delivery Device Market Challenges
8.4 Hydrogel-based Drug Delivery Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hydrogel-based Drug Delivery Device Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hydrogel-based Drug Delivery Device Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Hydrogel-based Drug Delivery Device Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Hydrogel-based Drug Delivery Device Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Hydrogel-based Drug Delivery Device Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Hydrogel-based Drug Delivery Device Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Hydrogel-based Drug Delivery Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Hydrogel-based Drug Delivery Device, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Product Types and Applications
 Table 12. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hydrogel-based Drug Delivery Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hydrogel-based Drug Delivery Device Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hydrogel-based Drug Delivery Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Hydrogel-based Drug Delivery Device Sales by Region (K Units), 2021–2026
 Table 18. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2021–2026)
 Table 19. Global Hydrogel-based Drug Delivery Device Sales by Region (K Units), 2027–2032
 Table 20. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2027–2032)
 Table 21. Global Hydrogel-based Drug Delivery Device Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2021–2026)
 Table 23. Global Hydrogel-based Drug Delivery Device Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2027–2032)
 Table 25. North America Hydrogel-based Drug Delivery Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Hydrogel-based Drug Delivery Device Sales by Country (K Units), 2021–2026
 Table 27. North America Hydrogel-based Drug Delivery Device Sales by Country (K Units), 2027–2032
 Table 28. North America Hydrogel-based Drug Delivery Device Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Hydrogel-based Drug Delivery Device Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Hydrogel-based Drug Delivery Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Hydrogel-based Drug Delivery Device Sales by Country (K Units), 2021–2026
 Table 32. Europe Hydrogel-based Drug Delivery Device Sales by Country (K Units), 2027–2032
 Table 33. Europe Hydrogel-based Drug Delivery Device Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Hydrogel-based Drug Delivery Device Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Hydrogel-based Drug Delivery Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Hydrogel-based Drug Delivery Device Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Hydrogel-based Drug Delivery Device Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Hydrogel-based Drug Delivery Device Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Hydrogel-based Drug Delivery Device Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Hydrogel-based Drug Delivery Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Hydrogel-based Drug Delivery Device Sales by Country (K Units), 2021–2026
 Table 42. Latin America Hydrogel-based Drug Delivery Device Sales by Country (K Units), 2027–2032
 Table 43. Latin America Hydrogel-based Drug Delivery Device Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Hydrogel-based Drug Delivery Device Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Hydrogel-based Drug Delivery Device Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Hydrogel-based Drug Delivery Device Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Hydrogel-based Drug Delivery Device Sales (K Units) by Type (2021–2026)
 Table 51. Global Hydrogel-based Drug Delivery Device Sales (K Units) by Type (2027–2032)
 Table 52. Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2021–2026)
 Table 53. Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2027–2032)
 Table 54. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2021–2026)
 Table 57. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2027–2032)
 Table 58. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Hydrogel-based Drug Delivery Device Sales (K Units) by Application (2021–2026)
 Table 61. Global Hydrogel-based Drug Delivery Device Sales (K Units) by Application (2027–2032)
 Table 62. Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2021–2026)
 Table 63. Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2027–2032)
 Table 64. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2021–2026)
 Table 67. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2027–2032)
 Table 68. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Application (2027–2032)
 Table 70. AstraZeneca Plc. Company Information
 Table 71. AstraZeneca Plc. Description and Business Overview
 Table 72. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product
 Table 74. AstraZeneca Plc. Recent Developments/Updates
 Table 75. Columbia Laboratories Inc. Company Information
 Table 76. Columbia Laboratories Inc. Description and Business Overview
 Table 77. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product
 Table 79. Columbia Laboratories Inc. Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Mylan Hydrogel-based Drug Delivery Device Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Teva Pharmaceuticals USA Inc. Company Information
 Table 86. Teva Pharmaceuticals USA Inc. Description and Business Overview
 Table 87. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product
 Table 89. Teva Pharmaceuticals USA Inc. Recent Developments/Updates
 Table 90. Blairex Laboratories Inc. Company Information
 Table 91. Blairex Laboratories Inc. Description and Business Overview
 Table 92. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product
 Table 94. Blairex Laboratories Inc. Recent Developments/Updates
 Table 95. ARx LLC. Company Information
 Table 96. ARx LLC. Description and Business Overview
 Table 97. ARx LLC. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. ARx LLC. Hydrogel-based Drug Delivery Device Product
 Table 99. ARx LLC. Recent Developments/Updates
 Table 100. Endo International plc Company Information
 Table 101. Endo International plc Description and Business Overview
 Table 102. Endo International plc Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Endo International plc Hydrogel-based Drug Delivery Device Product
 Table 104. Endo International plc Recent Developments/Updates
 Table 105. BioDelivery Sciences International Inc. Company Information
 Table 106. BioDelivery Sciences International Inc. Description and Business Overview
 Table 107. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product
 Table 109. BioDelivery Sciences International Inc. Recent Developments/Updates
 Table 110. Indivior PLC Company Information
 Table 111. Indivior PLC Description and Business Overview
 Table 112. Indivior PLC Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Indivior PLC Hydrogel-based Drug Delivery Device Product
 Table 114. Indivior PLC Recent Developments/Updates
 Table 115. GSK Plc Company Information
 Table 116. GSK Plc Description and Business Overview
 Table 117. GSK Plc Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. GSK Plc Hydrogel-based Drug Delivery Device Product
 Table 119. GSK Plc Recent Developments/Updates
 Table 120. Pfizer Inc. Company Information
 Table 121. Pfizer Inc. Description and Business Overview
 Table 122. Pfizer Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Pfizer Inc. Hydrogel-based Drug Delivery Device Product
 Table 124. Pfizer Inc. Recent Developments/Updates
 Table 125. Aquestive Therapeutics Inc. Company Information
 Table 126. Aquestive Therapeutics Inc. Description and Business Overview
 Table 127. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product
 Table 129. Aquestive Therapeutics Inc. Recent Developments/Updates
 Table 130. ZIM LABORATORIES LIMITED Company Information
 Table 131. ZIM LABORATORIES LIMITED Description and Business Overview
 Table 132. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product
 Table 134. ZIM LABORATORIES LIMITED Recent Developments/Updates
 Table 135. IntelGenx Corp. Company Information
 Table 136. IntelGenx Corp. Description and Business Overview
 Table 137. IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. IntelGenx Corp. Hydrogel-based Drug Delivery Device Product
 Table 139. IntelGenx Corp. Recent Developments/Updates
 Table 140. NEXGEL Company Information
 Table 141. NEXGEL Description and Business Overview
 Table 142. NEXGEL Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. NEXGEL Hydrogel-based Drug Delivery Device Product
 Table 144. NEXGEL Recent Developments/Updates
 Table 145. Bliss GVS Pharma Ltd. Company Information
 Table 146. Bliss GVS Pharma Ltd. Description and Business Overview
 Table 147. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product
 Table 149. Bliss GVS Pharma Ltd. Recent Developments/Updates
 Table 150. Teika Pharmaceutical Co. Ltd. Company Information
 Table 151. Teika Pharmaceutical Co. Ltd. Description and Business Overview
 Table 152. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product
 Table 154. Teika Pharmaceutical Co. Ltd. Recent Developments/Updates
 Table 155. Medherant Limited Company Information
 Table 156. Medherant Limited Description and Business Overview
 Table 157. Medherant Limited Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Medherant Limited Hydrogel-based Drug Delivery Device Product
 Table 159. Medherant Limited Recent Developments/Updates
 Table 160. Galderma Company Information
 Table 161. Galderma Description and Business Overview
 Table 162. Galderma Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Galderma Hydrogel-based Drug Delivery Device Product
 Table 164. Galderma Recent Developments/Updates
 Table 165. Johnson & Johnson Company Information
 Table 166. Johnson & Johnson Description and Business Overview
 Table 167. Johnson & Johnson Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Johnson & Johnson Hydrogel-based Drug Delivery Device Product
 Table 169. Johnson & Johnson Recent Developments/Updates
 Table 170. Bausch and Lomb Company Information
 Table 171. Bausch and Lomb Description and Business Overview
 Table 172. Bausch and Lomb Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 173. Bausch and Lomb Hydrogel-based Drug Delivery Device Product
 Table 174. Bausch and Lomb Recent Developments/Updates
 Table 175. Ferring B.V Company Information
 Table 176. Ferring B.V Description and Business Overview
 Table 177. Ferring B.V Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 178. Ferring B.V Hydrogel-based Drug Delivery Device Product
 Table 179. Ferring B.V Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Hydrogel-based Drug Delivery Device Distributors List
 Table 183. Hydrogel-based Drug Delivery Device Customers List
 Table 184. Hydrogel-based Drug Delivery Device Market Trends
 Table 185. Hydrogel-based Drug Delivery Device Market Drivers
 Table 186. Hydrogel-based Drug Delivery Device Market Challenges
 Table 187. Hydrogel-based Drug Delivery Device Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hydrogel-based Drug Delivery Device
 Figure 2. Global Hydrogel-based Drug Delivery Device Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hydrogel-based Drug Delivery Device Market Share by Type: 2025 & 2032
 Figure 4. Oral Product Picture
 Figure 5. Buccal Product Picture
 Figure 6. Rectal Product Picture
 Figure 7. Vaginal Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Hydrogel-based Drug Delivery Device Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Hydrogel-based Drug Delivery Device Market Share by Application: 2025 & 2032
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Other
 Figure 14. Global Hydrogel-based Drug Delivery Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Hydrogel-based Drug Delivery Device Market Size (US$ Million), 2021–2032
 Figure 16. Global Hydrogel-based Drug Delivery Device Sales (K Units), 2021–2032
 Figure 17. Global Hydrogel-based Drug Delivery Device Average Price (US$/Unit), 2021–2032
 Figure 18. Hydrogel-based Drug Delivery Device Report Years Considered
 Figure 19. Hydrogel-based Drug Delivery Device Sales Share by Manufacturers in 2025
 Figure 20. Global Hydrogel-based Drug Delivery Device Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Hydrogel-based Drug Delivery Device Players: Market Share by Revenue in Hydrogel-based Drug Delivery Device in 2025
 Figure 22. Hydrogel-based Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Hydrogel-based Drug Delivery Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Hydrogel-based Drug Delivery Device Sales Market Share by Country (2021–2032)
 Figure 25. North America Hydrogel-based Drug Delivery Device Revenue Market Share by Country (2021–2032)
 Figure 26. United States Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Hydrogel-based Drug Delivery Device Sales Market Share by Country (2021–2032)
 Figure 29. Europe Hydrogel-based Drug Delivery Device Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Hydrogel-based Drug Delivery Device Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2021–2032)
 Figure 37. China Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Hydrogel-based Drug Delivery Device Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Hydrogel-based Drug Delivery Device Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Hydrogel-based Drug Delivery Device Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Hydrogel-based Drug Delivery Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Hydrogel-based Drug Delivery Device by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Hydrogel-based Drug Delivery Device by Type (2021–2032)
 Figure 57. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Hydrogel-based Drug Delivery Device by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Hydrogel-based Drug Delivery Device by Application (2021–2032)
 Figure 60. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Application (2021–2032)
 Figure 61. Hydrogel-based Drug Delivery Device Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS